SB 365Alternative Names: Bai tou weng; Pulsatilla radix; SB Injection
Latest Information Update: 16 Jun 2015
At a glance
- Originator SBPharmaceutical
- Class Antineoplastics; Lignans
- Mechanism of Action Angiogenesis inhibitors; Tubulin polymerisation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer; Hepatocellular carcinoma; Non-small cell lung cancer
Most Recent Events
- 16 Jun 2015 No recent reports on development identified - Phase-II for Colorectal cancer, Hepatocellular carcinoma and Non-small cell lung cancer in South Korea (IV)